Unibest
← Back to patent-cliff list

CAS 78191-00-1

N-methoxy-N-methylacetamideN-Acetyl-N,O-dimethylhydroxylamine

Codes: ALPE-013, (XXXVIII)700647-1-e

Application context (from source-drug indications)

Growth disorderAlpelisibGenetic diseaseAlpelisibPIK3CA-related overgrowth spectrumAlpelisibBreast cancerAlpelisib蠕形螨性睑缘炎Lotilaner螨虫感染Lotilaner莱姆病LotilanerRosaceaLotilaner睑板腺功能障碍Lotilaner

Source drugs (routes using this intermediate)

DrugTierExpiry
AlpelisibTier C — Watch / trade2029
LotilanerTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

SupplierProductPrice bandMOQLead timeQualificationsAction
Unibest Nantong cGMP Site2-bromo-3-methyl-5-acetylthiophene
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Taizhou GMP-like Sitemethyl 5-acetyl-3-methylthiophene-2-carboxylate
Pharmaceutical Intermediates
On requestOn requestOn request
—
Qualified Partner — East China API Works5-acetyl-3-methyl-2-Thiophenecarboxylic acid
Pharmaceutical Intermediates
On requestOn requestOn request
—

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.